Cargando…

Recovery of Lung Function After 149 Days on Extracorporeal Membrane Oxygenation for COVID-19

This report highlights survival and the patient’s perspective after prolonged venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19–related respiratory failure. A 36-year-old man with COVID-19 presented with fever, anosmia, and hypoxia. After respiratory deterioration necessitating intu...

Descripción completa

Detalles Bibliográficos
Autores principales: Suero, Orlando R., Valluri, Sri Kartik, Farias-Kovac, Mario H., Simpson, Leo, Loor, Gabriel, Guerra, Diana M., Diaz-Gomez, Jose L., Chatterjee, Subhasis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Texas Heart® Institute, Houston 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658157/
https://www.ncbi.nlm.nih.gov/pubmed/37876039
http://dx.doi.org/10.14503/THIJ-23-8132
Descripción
Sumario:This report highlights survival and the patient’s perspective after prolonged venovenous extracorporeal membrane oxygenation (ECMO) for COVID-19–related respiratory failure. A 36-year-old man with COVID-19 presented with fever, anosmia, and hypoxia. After respiratory deterioration necessitating intubation and lung-protective ventilation, he was referred for ECMO. After 3 days of conventional venovenous ECMO, he required multiple creative cannulation configurations. Adequate sedation and recurrent bradycardia were persistent challenges. After 149 consecutive days of ECMO, he recovered native lung function and was weaned from mechanical ventilation. This represents the longest-duration ECMO support in a survivor of COVID-19 yet reported. Necessary strategies included unconventional cannulation and flexible anticoagulation.